Politico Pro reporter Sarah Owermohle told 340B Coalition winter conference attendees she thinks President Biden will turn to drug pricing after dealing first with the COVID-19 pandemic and bolstering the Affordable Care Act.

Health Care Reporter Foresees Federal Action on Drug Pricing, But Not Immediately

The U.S. Senate Finance Committee’s new Democratic chair is considering bringing back a bipartisan bill from the last session of Congress that would require drug manufacturers to pay the federal government rebates on Medicare Part B and Part D drugs for which prices rise faster than the rate of inflation, Political Pro health care reporter Sarah Owermohle told 340B stakeholders on Tuesday during a talk about drug pricing reform.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
×

Sign up for news summaries and alerts from 340B Report